367 related articles for article (PubMed ID: 16681581)
1. Treatment of vulval Crohn's disease with infliximab.
Preston PW; Hudson N; Lewis FM
Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
[TBL] [Abstract][Full Text] [Related]
2. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Barthel HR; Gille T; Halbsguth A; Kramer M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
[No Abstract] [Full Text] [Related]
4. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Rutgeerts P; Van Assche G; Vermeire S
Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
[TBL] [Abstract][Full Text] [Related]
5. Infliximab use in luminal Crohn's disease.
Richter JA; Bickston SJ
Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813
[TBL] [Abstract][Full Text] [Related]
6. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease.
Sorrentino D; Terrosu G; Avellini C; Maiero S
Arch Intern Med; 2007 Sep; 167(16):1804-7. PubMed ID: 17846401
[No Abstract] [Full Text] [Related]
7. Metastatic vulval Crohn's disease and infliximab: a case report.
Tritton SM; Whyte L; Fischer G
J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
[TBL] [Abstract][Full Text] [Related]
8. Prediction of response to infliximab in Crohn's disease.
Chaudhary R; Ghosh S
Dig Liver Dis; 2005 Aug; 37(8):559-63. PubMed ID: 15893967
[No Abstract] [Full Text] [Related]
9. Vulval Crohn's disease: a clinical study of 22 patients.
Laftah Z; Bailey C; Zaheri S; Setterfield J; Fuller LC; Lewis F
J Crohns Colitis; 2015 Apr; 9(4):318-25. PubMed ID: 25687208
[TBL] [Abstract][Full Text] [Related]
10. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
11. The management of fistulizing oral Crohn's disease with infliximab.
Staines KS; Green R; Felix DH
J Oral Pathol Med; 2007 Aug; 36(7):444-6. PubMed ID: 17617840
[TBL] [Abstract][Full Text] [Related]
12. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
[TBL] [Abstract][Full Text] [Related]
13. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
14. Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease.
Ahmad NM; Ahmad KM; Younus F
J Infect; 2007 Jan; 54(1):e29-32. PubMed ID: 16678268
[TBL] [Abstract][Full Text] [Related]
15. Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease.
Tsujikawa T; Nezu R; Andoh A; Saotome T; Araki Y; Ishizuka Y; Sasaki M; Koyama S; Fujiyama Y
J Gastroenterol; 2004; 39(3):284-7. PubMed ID: 15065007
[TBL] [Abstract][Full Text] [Related]
16. Anti-TNF treatment in Crohn's disease: toward tailored therapy?
D'Haens G
Am J Gastroenterol; 2010 May; 105(5):1140-1. PubMed ID: 20445512
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease.
Candon S; Mosca A; Ruemmele F; Goulet O; Chatenoud L; Cézard JP
Clin Immunol; 2006 Jan; 118(1):11-9. PubMed ID: 16125467
[TBL] [Abstract][Full Text] [Related]
18. Algorithm for the treatment of Crohn's disease: incorporation of emerging therapies.
Souney PF
Am J Gastroenterol; 2000 Sep; 95(9):2381-3. PubMed ID: 11007248
[No Abstract] [Full Text] [Related]
19. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
20. Managing complicated Crohn's disease in children and adolescents.
Homan M; Baldassano RN; Mamula P
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]